References
- Statistical Office. Population and Housing Census Survey Sample Aggregation Results (Women, Children, Elderly People, etc.). Statistics Korea, 2015
- Birrer RB, Vemuri SP. Depression in later life: a diagnostic and therapeutic challenge. Am Fam Physician 2004;69:2375-2382.
- Cole MG, Dendukuri N. Risk factors for depression among elderly community subjects: systematic review and meta-analysis. Am J Psychiatry 2003;160:1147-1156. https://doi.org/10.1176/appi.ajp.160.6.1147
- Boswell EB, Stoudemire A. Major Depression in the primary care setting. Am J Med 1996;101:3S-9S.
- Health Insurance Policy Research Institute National Health Insurance Corporation [NHIC];2013.
- Hans PK. Somatic symptoms in depression. Dialogues Clin Neurosci 2006;8:227-239. https://doi.org/10.31887/DCNS.2006.8.2/hpkapfhammer
- Schappert SM. National Ambulatory Medical Care Survey, 991 Summary, 1994.
- Roh S, Park YC. Characteristics of depression in Korea and non-pharmacological treatment. Korean J Biol Psychiatry 2006;13:226-233.
- Kim Im. Elderly psychiatry. Edited by Min Sung-gil. The Latest Psychiatry 6th Edition. Seoul: Sculpture;2015. p.724-738.
- Yun KW, Kim SI. The influence of life stress on the severity of depression and somatic symptoms in depressive women. J Korean Neuropsychiatr Assoc 2010;49:304-311.
- Song JY, Park JC, Park JH, Oh DJ, Sohn HS, Chung KJ. Frequency and clinical characteristics of pain of the patients in psychiatric out-patient clinics. J Korean Neuropsychiatr Assoc 1999;38:1402-1411.
- Brodaty H, Harris L, Peters K, Wilhelm K, Hickie I, Boyce P, Mitchell P, Parker G, Eyers K. Prognosis of depression in the elderly. A comparison with younger patients. Br J Psychiatry 1993;163:589-596. https://doi.org/10.1192/bjp.163.5.589
- Gerber PD, Barrett JE, Barrett JA, Oxman TE, Manheimer E, Smith R, Whiting RD. The relationship of presenting physical complaints to depressive symptoms in primary care patients. J Gen Intern Med 1992;7:170-173. https://doi.org/10.1007/BF02598007
- Papakostas GI, Petersen T, Denninger J, Sonawalla SB, Mahal Y, Alpert JE, Nierenberg AA, Fava M. Somatic symptoms in treatment-resistant depression. Psychiatry Research 2003;118:39-45. https://doi.org/10.1016/S0165-1781(03)00063-5
- Alexopoulos GS. Pharmacotherapy for late-life depression. J Clin Psychiatry 2011;72:e04. https://doi.org/10.4088/JCP.7085tx2cj
- Solai LK, Mulsant BH, Pollock BG. Selective serotonin reuptake inhibitors for late-life depression. Drugs & Aging 2001;18:355-368. https://doi.org/10.2165/00002512-200118050-00006
- Cole MG, Elie LM, McCusker J, Bellavance F, Mansour A. Feasibility and effectiveness of treatments for post-stroke depression in elderly inpatients: systematic review. J Geriatr Psychiatry Neurol 2001;14:37-41. https://doi.org/10.1177/089198870101400109
- Cole MG. Feasibility and effectiveness of treatments for depression in elderly medical inpatients: a systematic review. Int Psychogeriatr 2000;12:453-461. https://doi.org/10.1017/S1041610200006578
- Mulsant BH, Pollock BG, Nebes RD, Miller MD, Little JT, Stack J, Houck PR. A double-blind randomized comparison of nortriptyline and paroxetine in the treatment of late-life depression: 6-week outcome. J Clin Psychiatry 1999;60:16-20.
- Bird H, Broggini M. Paroxetine versus amitriptyline for treatment of depression associated with rheumatoid arthritis: a randomized, double blind, parallel group study. J Rheumatol 2000;27:2791-2797.
- Emslie G, Judge R. Tricyclic antidepressants and selective serotonin reuptake inhibitors: use during pregnancy, in children/adolescents and in the elderly. Acta Psychiatrica Scandinavica 2000;101:26-34. https://doi.org/10.1111/j.1600-0447.2000.tb10945.x
- Arnold LM. Duloxetine and other antidepressants in the treatment of patients with fibromyalgia. Pain Medicine 2007;8:S63-S74. https://doi.org/10.1111/j.1526-4637.2006.00178.x
- Perahia DG, Pritchett YL, Desaiah D, Raskin J. Efficacy of duloxetine in painful symptoms: an analgesic or antidepressant effect? Int Clin Psychopharmacol 2006;21:311-317. https://doi.org/10.1097/01.yic.0000224782.83287.3c
- Pernia A, Mico J-A, Calderon E, Torres LM. Venlafaxine for the treatment of neuropathic pain. J Pain Symptom Manage 2000;19:408-410. https://doi.org/10.1016/S0885-3924(00)00151-2
- Max MB, Lynch SA, Muir J, Shoaf SE, Smoller B, Dubner R. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992;326:1250-1256. https://doi.org/10.1056/NEJM199205073261904
- Moon DE. Consideration of antidepressants in patients with chronic pain. J Korean Pain Soc 2004;17:S54-S62. https://doi.org/10.3344/kjp.2004.17.S.S54
- Arnold LM, Hess EV, Hudson JI, Berno SE, Keck PEA. Randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia. Am J Med 2002;112:191-197. https://doi.org/10.1016/S0002-9343(01)01089-0
- Mallinckrodt CH, Prakash A, Houston JP, Swindle R, Detke MJ, Fava M. Differential antidepressant symptom efficacy: placebo-controlled comparisons of duloxetine and SSRIs (fluoxetine, paroxetine, escitalopram). Neuropsychobiology 2007;56:73-85. https://doi.org/10.1159/000111537
- Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry Res 1960;23:56. https://doi.org/10.1136/jnnp.23.1.56
- Yi JS, Bae SO, Ahn YM, Park DB, Noh KS, Shin HK, Woo HW. Validity and Reliability of the Korean Version of the Hamilton Depression Rating Scale (K-Hdrs). J Korean Neuropsychiatr Assoc 2005;44:456-465.
- DeLoach LJ, Higgins MS, Caplan AB, Stiff JL. The visual analog scale in the immediate postoperative period: intrasubject variability and correlation with a numeric scale. Anesthesia & Analgesia 1998;86:102-106. https://doi.org/10.1213/00000539-199801000-00020
- Kroenke K, Spitzer RL, Williams JB. The Phq-15: validity of a new measure for evaluating the severity of somatic symptoms. J Psychosom 2002;64:258-266. https://doi.org/10.1097/00006842-200203000-00008
- Han C, Pae CU, Patkar AA. Psychometric properties of the Patient Health Questionnaire-15 (PHQ-15) for measuring the somatic symptoms of psychiatric outpatients. Psychosom 2009;50:580-585. https://doi.org/10.1016/S0033-3182(09)70859-X
- Berger A, Dukes E, Edelnerg J, Stacey B, Oster G. Use of tricyclic antidepressants in older patients with diabetic peripheral neuropathy. Clin J Pain 2007;23:251-258. https://doi.org/10.1097/AJP.0b013e31802f67dd
- Sindrup SH, Jensen TS. Pharmacologic treatment of pain in polyneuropathy. Neurology 2000;55:915-920. https://doi.org/10.1212/WNL.55.7.915
- Lee SS. Diagnosis and treatment of fibromyalgia syndrome. The Korean J Med 2013;84:650-658. https://doi.org/10.3904/kjm.2013.84.5.650
- Hauser W, Thieme K, Turk DC. Guidelines on the management of fibromyalgia syndrome a systematic review. Eur J Pain 2010;11;505-521. https://doi.org/10.1016/j.jpain.2010.01.002
- Patkar AA, Masand PS, Krulewicz S, Mannelli P, Peindl K, Beebe KL. A randomized, controlled, trial of controlled release paroxetine in fibromyalgia. Am J Med 2007;120:448-454. https://doi.org/10.1016/j.amjmed.2006.06.006
- Anderberg UM, Marteinsdottir I, von Knorring L. Citalopram in patients with fibromyalgia--a randomized, doubleblind, placebo-controlled study. Eur J Pain 2000;4:27-35. https://doi.org/10.1053/eujp.1999.0148
- Otto M, Bach FW, Jensen TS, Brosen K, Sindrup SH. Escitalopram in painful polyneuropathy: a randomized, placebo- controlled, cross-over trial. Pain 2008;139:275-83. https://doi.org/10.1016/j.pain.2008.04.012
- Watson CPN, Evans RJ. The postmastectomy pain syndrome and topical capsaicin: a randomized trial. Pain 1992;51:375-379. https://doi.org/10.1016/0304-3959(92)90223-X
- Geisser ME, Roth RS, Robinson ME. Assessing depression among persons with chronic pain using the Center for Epidemiology Studies-Depression Scale and Beck Depression inventory: a compariative analysis. Clin J Pain 1997;13:163-170 https://doi.org/10.1097/00002508-199706000-00011
- Bair MJ, Robinson RL, Katon W, Kroenke K. Depression and pain comorbidity: a literature review. Archives of Internal Medicine 2003;163:2433-2445. https://doi.org/10.1001/archinte.163.20.2433
- Melzack R. Gate control theory: on the evolution of pain concepts. Pain Forum 1996;5:128-138. https://doi.org/10.1016/S1082-3174(96)80050-X
- Melzack R. From the gate to the neuromatrix. Pain 1999;82:S121-S126. https://doi.org/10.1016/S0304-3959(99)00145-1
- Campbell LC, Clauw DJ, Keefe FJ. Persistent pain and depression: a biopsychosocial perspective. Biol Psychiatry 2003;54:399-409. https://doi.org/10.1016/S0006-3223(03)00545-6
- D'Sa C, Duman RS. Antidepressants and neuroplasticity. Bipolar Disord 2002;4:183-194. https://doi.org/10.1034/j.1399-5618.2002.01203.x
- Lee AL, Ogle WO, Sapolsky RM. Stress and depression: possible links to neuron death in the hippocampus. Bipolar Disord 2002;4:117-128. https://doi.org/10.1034/j.1399-5618.2002.01144.x
- Mitchell BM, Sue AL, Joanne M, Susan ES. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992;326:1250-1256 https://doi.org/10.1056/NEJM199205073261904
- Engel CC, Walker EA, Engel AL, Bullis J, Armstrong A. A randomized, double-blind crossover trial of sertraline in women with chronic pelvic pain. J Psychosom Res 1998;44:203-207. https://doi.org/10.1016/S0022-3999(97)00215-8
- Mico JA, Ardid D, Berrocoso E, Eschalier A. Antidepressants and pain. Trends Pharmacol Sci 2006;27:348-354. https://doi.org/10.1016/j.tips.2006.05.004
- Tylee A, Gaspar M, Lepine JP, Mendlewicz J. DEPRES II. Depression Research in European Society II: a patient survey of the symptoms, disability and current management of depression in the community. DEPRES Steering Committee. Int J Psychopharmacol 1999;14:139-151.
- Simon GE, VonKorff M, Piccinelli M, Fullerton C, Ormel J. An international study of the relation between somatic symptoms and depression. N Engl J Med 1999;341:1329-1335. https://doi.org/10.1056/NEJM199910283411801
- Denninger JW, Papakostas GI, Mahal Y, Merens W, Alpert JE, Nierenberg AA, Yeung A, Fava M. Somatic symptoms in outpatients with major depressive disorder treated with fluoxetine. Psychosom 2006;47:348-352. https://doi.org/10.1176/appi.psy.47.4.348
- Broekaert D, Gevers A, Janssens J. A double blind randomized placebo controlled crossover trial of citalopram, a selective 5-hydroxytryptamine reuptake inhibitor, in irritable bowel syndrome. Gastroenterology 2001;120:32-50.
- Kroenke K, Messina 3rd N, Benattia I, Graepel J, Musgnung J. Venlafaxine extended release in the short-term treatment of depressed and anxious primary care patients with multisomatoform disorder. J Clin Psychiatry 2006;67:72-80. https://doi.org/10.4088/JCP.v67n0111
- Hojo M, Miwa H, Yokoyama T, Ohkusa T, Nagahara A, Kawabe M, Asaoka D, Izumi Y, Sato N. Treatment of functional dyspepsia with antianxiety or antidepressive agents: systematic review. Journal of Gastroenterology 2005;40:1036-1042. https://doi.org/10.1007/s00535-005-1687-8
- Wu CY, Chou LT, Chen HP, Chang CS, Wong PG, Chen GH. Effect of fluoxetine on symptoms and gastric dysrhythmia in patients with functional dyspepsia. Hepato-Gastroenterology 2003;50:278-283.
- Herschbach P, Henrich G, von Rad M. Psychological factors in functional gastrointestinal disorders: characteristics of the disorder or of the illness behavior? Psychosom Med 1999;61:148-153. https://doi.org/10.1097/00006842-199903000-00005
- Hegeman JM, de Waal MW, Comijs HC, Kok RM, van der Mast RC. Depression in later life: a more somatic presentation? J Affect Disord 2015;170:196-202. https://doi.org/10.1016/j.jad.2014.08.032
- Wang YW, Lee CU. Pharmacological treatment of psychiatric disorders of the elderly. J Korean Med Assoc 2010;53:972-983 https://doi.org/10.5124/jkma.2010.53.11.972